Nonalcoholic steatohepatitis (NASH) is a progressive form of nonalcoholic fatty liver disease that can lead to irreversible liver cirrhosis and cancer. Early diagnosis of NASH is vital to detect disease before it becomes life-threatening, yet noninvasively differentiating NASH from simple steatosis is challenging. Herein, bifunctional probes have been developed that target the hepatocyte-specific asialoglycoprotein receptor (ASGPR), the expression of which decreases during NASH progression. The results show that the probes allow longitudinal, noninvasive monitoring of ASGPR levels by positron emission tomography in the newly developed rat model of NASH. The probes open new possibilities for research into early diagnosis of NASH and development of drugs to slow or reverse its progression.
Keywords: Zucker fatty/spontaneously hypertensive heart failure F1 hybrid rats; asialoglycoprotein receptor; insulin resistance; nonalcoholic steatohepatitis; obesity; positron emission tomography imaging; β‐d‐galactose or N‐acetylgalactosamine.
© 2020 The Authors. Published by Wiley‐VCH GmbH.